Herbalife Nutrition (NYSE:HLF) announced its quarterly earnings results on Thursday. The company reported $0.70 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.05), Bloomberg Earnings reports. Herbalife Nutrition had a net margin of 6.36% and a negative return on equity of 56.65%. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter in the prior year, the business posted $0.80 EPS. The business’s quarterly revenue was down 3.5% on a year-over-year basis.
Shares of NYSE:HLF traded down $2.76 during trading on Friday, hitting $38.00. 6,353,187 shares of the company traded hands, compared to its average volume of 2,068,478. The company has a market capitalization of $6.20 billion, a PE ratio of 13.19 and a beta of 0.43. The stock has a fifty day simple moving average of $42.02. Herbalife Nutrition has a one year low of $36.62 and a one year high of $61.77.
In other news, SVP Edi Hienrich sold 738 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $47.62, for a total transaction of $35,143.56. Following the completion of the sale, the senior vice president now owns 22,246 shares of the company’s stock, valued at approximately $1,059,354.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 6.31% of the stock is currently owned by corporate insiders.
Several equities analysts have issued reports on HLF shares. ValuEngine upgraded Herbalife Nutrition from a “sell” rating to a “hold” rating in a research note on Thursday. Pivotal Research reiterated a “buy” rating and issued a $65.00 target price (down previously from $75.00) on shares of Herbalife Nutrition in a research note on Friday. BMO Capital Markets reiterated a “hold” rating and issued a $9.00 target price on shares of Herbalife Nutrition in a research note on Friday, May 17th. Citigroup cut their target price on Herbalife Nutrition from $66.00 to $57.00 and set a “buy” rating on the stock in a research note on Friday. Finally, Argus lowered Herbalife Nutrition from a “buy” rating to a “hold” rating in a research note on Wednesday, April 10th. Five investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $55.17.
Herbalife Nutrition Company Profile
Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.